RESUMEN
In this study, 37 derivatives of phorbol esters were synthesized and their anti-HIV-1 activities evaluated, building upon our previous synthesis of 51 phorbol derivatives. 12-Para-electron-acceptor-trans-cinnamoyl-13-decanoyl phorbol derivatives stood out, demonstrating remarkable anti-HIV-1 activities and inhibitory effects on syncytia formation. These derivatives exhibited a higher safety index compared with the positive control drug. Among them, 12-(trans-4-fluorocinnamoyl)-13-decanoyl phorbol, designated as compound 3c, exhibited the most potent anti-HIV-1 activity (EC50 2.9 nmol·L-1, CC50/EC50 11 117.24) and significantly inhibited the formation of syncytium (EC50 7.0 nmol·L-1, CC50/EC50 4891.43). Moreover, compound 3c is hypothesized to act both as an HIV-1 entry inhibitor and as an HIV-1 reverse transcriptase inhibitor. Isothermal titration calorimetry and molecular docking studies indicated that compound 3c may also function as a natural activator of protein kinase C (PKC). Therefore, compound 3c emerges as a potential candidate for developing new anti-HIV drugs.
Asunto(s)
Fármacos Anti-VIH , Forboles , Simulación del Acoplamiento Molecular , Fármacos Anti-VIH/farmacología , Fármacos Anti-VIH/química , Forboles/química , Forboles/farmacología , Ésteres del Forbol/farmacología , Transcriptasa Inversa del VIH/química , Transcriptasa Inversa del VIH/metabolismo , Relación Estructura-ActividadRESUMEN
Phorbol esters are recognized for their dual role as anti-HIV-1 agents and as activators of protein kinase C (PKC). The efficacy of phorbol esters in binding with PKC is attributed to the presence of oxygen groups at positions C20, C3/C4, and C9 of phorbol. Concurrently, the lipids located at positions C12/C13 are essential for both the anti-HIV-1 activity and the formation of the PKC-ligand complex. The influence of the cyclopropane ring at positions C13 and C14 in phorbol derivatives on their anti-HIV-1 activity requires further exploration. This research entailed the hydrolysis of phorbol, producing seco-cyclic phorbol derivatives. The anti-HIV-1 efficacy of these derivatives was assessed, and the affinity constant (Kd) for PKC-δ protein of selected seco-cyclic phorbol derivatives was determined through isothermal titration calorimetry. The findings suggest that the chemical modification of cyclopropanols could affect both the anti-HIV-1 activity and the PKC binding affinity. Remarkably, compound S11, with an EC50 of 0.27 µmol·L-1 and a CC50 of 153.92 µmol·L-1, demonstrated a potent inhibitory effect on the intermediate products of HIV-1 reverse transcription (ssDNA and 2LTR), likely acting at the viral entry stage, yet showed no affinity for the PKC-δ protein. These results position compound S11 as a potential candidate for further preclinical investigation and for studies aimed at elucidating the pharmacological mechanism underlying its anti-HIV-1 activity.
Asunto(s)
Fármacos Anti-VIH , VIH-1 , VIH-1/efectos de los fármacos , Humanos , Fármacos Anti-VIH/farmacología , Fármacos Anti-VIH/química , Ésteres del Forbol/farmacología , Ésteres del Forbol/química , Estructura Molecular , Proteína Quinasa C/metabolismo , Proteína Quinasa C/química , Relación Estructura-ActividadRESUMEN
In Brazil, latex from Euphorbia umbellata (African milk tree) has been increasingly used in folk medicine to treat several types of cancer, including melanoma. The effect of lyophilized latex (LL), its hydroethanolic extract (E80), triterpene (F-TRI)- and diterpene (F-DIT)-enriched fractions, along with six isolated phorbol esters from LL and phorbol 12-myristate 13-acetate (PMA) on J774A.1, THP-1, SK-MEL-28, and B16-F10 cell line viability were evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) method. The compounds were identified by 2D-NMR and HRESIMS. The effect of the LL, extract and fractions on cell viability was also assessed through a resazurin reduction assay. At 100 µg/ml, LL, and its fractions moderately inhibited J774A.1 (37.5-59.5%) and THP-1 (12.6-43.6%) metabolism. LL (IC50 70 µg/ml) and F-TRI (IC50 68 µg/ml) were barely more effective against B16-F10 cells, and only F-TRI exerted an inhibitory effect on SK-MEL-28 cells (IC50 66-75 µg/ml). The samples did not effectively inhibit THP-1 growth (IC50 69-87 µg/ml, assessed by MTT). B16-F10 was susceptible to PMA (IC50 53 µM) and two 12-phenylacetate esters (IC50 56-60 µM), while SK-MEL-28 growth was inhibited (IC50 58 µM) by one of these kinds of esters with an additional 4ß-deoxy structure. Synagrantol A (IC50 39 µM) was as effective as PMA (IC50 47 µM) in inhibiting J774A.1 growth in a dose-dependent manner. Furthermore, an in silico study with target receptors indicated a high interaction of the compounds with the PKC proteins. These results provide useful knowledge on the effect of tigliane-type diterpenes on tumor cell from the perspective of medicinal chemistry.
Asunto(s)
Euphorbia , Látex , Ésteres del Forbol , Euphorbia/química , Látex/química , Ésteres del Forbol/farmacología , Humanos , Ratones , Animales , Línea Celular Tumoral , Estructura Molecular , Extractos Vegetales/farmacología , Extractos Vegetales/química , Brasil , Monocitos/efectos de los fármacos , Fitoquímicos/farmacología , Fitoquímicos/aislamiento & purificación , Supervivencia Celular/efectos de los fármacos , Diterpenos/farmacología , Diterpenos/aislamiento & purificación , Terpenos/farmacología , Terpenos/aislamiento & purificación , Antineoplásicos Fitogénicos/farmacología , Antineoplásicos Fitogénicos/aislamiento & purificación , Acetato de Tetradecanoilforbol , Melanoma/tratamiento farmacológicoRESUMEN
Thymeleatoxin (TMX), an activator of Ca2+-sensitive protein kinase C (cPKC) isoforms, was used to assess the PKC isoform specificity of cholinergic potentiation of glucose (11 mM)-induced pulsatile 5-HT/insulin release (PIR) from single mouse pancreatic islets. TMX (100 nM) and carbachol (Cch, 50 mM) enhanced PIR ~ 3-fold while reducing the underlying [Ca2+]i oscillations (duration and amplitude) by ~ 40-50 percent. Both effects were ablated by the specific PKC inhibitor bisindolylmaleimide and chronic TMX pretreatment. Cch also evoked an initial transient [Ca2+]i rise and surge of 5-HT release, which remained unaffected by chronic TMX pretreatment. It is concluded that the immediate cholinergic responses are insensitive to cPKC. In contrast, specific activation of a cPKC isoform mediates sustained cholinergic potentiation of glucose-induced insulin secretion.
Asunto(s)
Animales , Ratones , Glucosa/metabolismo , Insulina , Islotes Pancreáticos , Ésteres del Forbol/farmacología , Proteína Quinasa C/efectos de los fármacos , Serotonina/metabolismo , Señalización del Calcio/efectos de los fármacos , Carbacol/farmacología , Agonistas Colinérgicos/farmacología , Electroquímica , Fluorometría , Islotes Pancreáticos/efectos de los fármacos , Proteína Quinasa C/metabolismo , Flujo Pulsátil/efectos de los fármacosRESUMEN
Ab: Homotropic T cell adhesion, as generally studied, consists of a rapid, transient binding process that is measured over a 15-120 min. period. Here we report a slow type of adhesion process occurring with human or rhesus T cells, purified from peripheral blood, that manifests itself by the formation of rounded, multi-layer clusters which may contain hundreds of cells. The maximal number and size of the clusters peak 1-2 days after the addition of phorbol ester, an absolute requirement. The number of clusters formed is proportional to phorbol ester concentration up to 1.25 ng/mL. Phorbol esters such as phorbol myristate acetate (PMA), phorbol dibutyrate (PDB), and 7-octylindolactam (OIL) induced optimal cluster formation at 1-13 ng/mL, levels slightly higher than that required to induce mitogenesis of purified T cells. Phorbol itself and the alpha-form of the ester were inactive. Both cluster formation and mitogenesis (stimulated by Con A or anti-CD3) are completely inhibited by staurosporin at 12.5 ng/mL. Even at 2.5 ng/mL, 74 percent of cluster formation was inhibited, which strongly implies a crucial role for protein kinase C. In the presence of accessory cells, T cell clusters were suppressed. Monoclonal Ab such as anti-CD3, mouse anti-CD3 followed by anti-mouse IgG, anti-CD4, anti-CD4A, anti-CD2, anti-CD8, and anti-CD45 did not induce cluster formation. None were inhibitory or stimulatory in the presence of PMA, except for anti-CD3 which enhanced cluster formation by 26 percent. However, anti-LFA-1 beta-chain (mouse monoclonal) completely blocked cluster formation over the range studied (63-1000 ng/mL) for both human and rhesus cells; rat anti-LFA-1 only blocked human cell adhesion. Anti LFA-1 only partially inhibited T cell mitogenesis. These results show that slow cluster formation shares the LFA-1 and phorbol ester requirements of the rapid adhesion of T cells requiring LFA-1 and ICAM-1. However, cluster occurs at a very low phorbol ester concentration, appears more sensitive to staurosporin inhibition, and is not stimulated via the TCR receptor like the rapid adhesion process. We hypothesize that certain neuronal processes, induced by phorbol ester, and which also show a similar protein kinase C activation time course, may share mechanisms in common with cluster formation
Asunto(s)
Humanos , Animales , Ratas , Ratones , Adhesión Celular/inmunología , Agregación Celular/inmunología , Prueba de Inhibición de Adhesión Leucocitaria , Antígeno-1 Asociado a Función de Linfocito/fisiología , Proteína Quinasa C/fisiología , Linfocitos T/inmunología , Adhesión Celular , Agregación Celular , Ésteres del Forbol/farmacología , Macaca mulatta , Activación de Linfocitos , Activación de Linfocitos/inmunologíaRESUMEN
La activación de alfa2-adrenoreceptores o Ri-adenosinreceptores en células adiposas disminuyó considerablemente la acumulación de AMP cíclico inducido por el agonista beta-adrenérgico isoprenalina. Esta acción casi fue abolida en células de hamster tratadas con toxina de la tosferina. El ester forbol activo, forbol 12-miristrato 13 acetato, fue incapaz de reproducir el efecto de la toxina en este modelo. Los datos indican que la activación de la proteinoquinasa C en este modelo celular no altera la rama inhibitoria de la adenil ciclasa
Asunto(s)
Cricetinae , Animales , Adenilil Ciclasas/metabolismo , Tejido Adiposo/enzimología , Toxina del Pertussis/administración & dosificación , Ésteres del Forbol/farmacología , Agonistas alfa-Adrenérgicos , Ésteres del Forbol/metabolismoRESUMEN
Ha sido demostrado que el etanol y el acetaldehido inhiben la esteroidogenesis testicular. No obstante el (los) mecanismo(s) de trasnducción de señal envuelto en su acción no fue aún elucidado. Hemos examinado el posible envolvimiento de la proteína quinasa sensible a fosfolípidos y dependiente de calcio (proteína quinasa C, PK-C) en el mecanismo intracelular de acción de etanol y de acetaldehido, estimulando la producción de testosterona en células intersticiales de testículo de rata con LHRH y éster de forbolPDBu, los cuales activan la PK-C a nivel de receptor (LHRH) y pos-receptor (PDBu). El etanol(2000 mg por ciento) inhibió la producción de testosterona estimulada con 10**-7 M LHRH y 200 nM PDBu en 81 + 4,7 por ciento y 60 + 20.4 por ciento respectivamente. El acetaldehido (20 mg por ciento) redujo la cantidad de testosterona producida por 10**-7 M LHRH y 200 nM PDBu en 59,4 + 1,2 por ciento, respectivamente. El nivel basal de testosterona no fue modificado por el etanol pero si fue reducido por el acetaldehido. No obstante, la prueba funcional de la viabilidad celular a través de la preincubación de las células con las referidas dosis de etanol y acetaldehido no disminuyó la capacidad de respuesta a una subsecuente estimulación con LHRH, demostrando que la viabilidad celular no fue afectada por la incubación con esas substancias. Los resultados aquí presentados sugieren que la exposición directa al etanol y acetaldehido redujo la habilidad de las células intersticiales del testículo de rata de responder a la estimulación de la vía mediada por la PK-C
Asunto(s)
Animales , Masculino , Ratas , Acetaldehído/farmacología , Ésteres del Forbol/farmacología , Etanol/farmacología , Hormona Liberadora de Gonadotropina/efectos de los fármacos , Técnicas In Vitro , Ratas Wistar , Testículo/citología , Testosterona/biosíntesis , Testosterona/metabolismoRESUMEN
We have investigated the effect of prostaglandin E2 (PGE2) on the T lymphocyte activation pathway. 2. At physiologically attainable concentrations (-0.1 micronM), PGE2 effectively inhibited the proliferation of murine antigen0specific "helper" T cell clones stimulated either with specific antigen in the presence of macrophages or with phorbol ester plus calcium ionophore A23187. The inhibition was not reversed by the addition of exogenous Interleukin 2(IL-2) in either case. 3. PGE treatment at the same concentrations did not inhibit IL-2 production by phorbol ester plus calcium ionophore-stimulated T cell clones as assayed by CTLL proliferation. 4. These results suggest that the major target (or targets) of PGE) inhibition directly on T cells lies in the IL-2 signal transduction pathway rather than in the early activation events leading to T cell activation
Asunto(s)
Ratones , Animales , Células Clonales/efectos de los fármacos , Ésteres del Forbol/farmacología , Interleucina-2/fisiología , Prostaglandinas E/farmacología , Linfocitos T/efectos de los fármacos , Transducción GenéticaRESUMEN
We have investigated the role of protein kinase C (PK-C) in luteinizing hormone-releasing hormone (LHRH)-induced testosterone secretion from purified rat Leydig cells (70-80-day old Sprague-Dawley rats) by pretreating the cells in vitro with 200 mM phorbol 12,13-dibutyrate (PDBu) (a known procedure to down-modulate this enzyme in most cell types) and 1 muM [D-Ala6,Des-Glyl0]-LHRH ethylamide, an LHRH agonist (LHRH-A). Following pretreatment we measured PK-C activity and secretion of testosterone in response to subsequent challenges with the PK-C activator PDBu (20-2000 nM) and with LHRH (0.001-1.0 muM) and the Ca2+ mobilizing secretagogue A23187 (0.1-1OO muM) in the same cell preparation. PDBu and LHRH-A pretreatments caused a reduction in testosterone secretion in response to subsequent exposure to PDBu or LHRH. Both pretreatments decreased PK-C activity in crude and purified extracts of the same cells. The magnitude of reduction of the secretory response was greater than that of enzyme activity for both PDBu and LHRH-A pretreatment (68.9 per cent reduction of testosterone secretion vs 54.7 per cent reduction of PK-C activity in PDBu-pretreated cells and 78.6 per cent reduction of testosterone production vs 36.6 per cent reduction of PK-C activity in LHRH-A-pretreated cells). The effect of phorbol ester pretreatment on PDBu- or LHRH-stimulated testosterone secretion and PK-C activity was specific (no measurable effect with 4 alpha-PDBu, an inactive phorbol ester). While PDBu and LHRH-A pretreatment reduced Leydig cell responsiveness to PDBu or LHRH, the secretion of testosterone in response to the Ca2+ -mobilizing secretagogue A23187 was similar in PDBu- and LHRH-A-pretreated and in control (non-pretreated) cells. We conclude that down-modulation of protein kinase C by prolonged exposure of Leydig cells to phorbol esters or LHRH-A results in decreased PK-C activity and testosterone secretion. These results provide the first evidence that pretreatment with LHRH-A, which does not enter the cell, can affect the steroidogenesis and PK-C activity responses to PDBu (the intracellular ligand of PK-C).